Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma

Clinical trial NCT00005949 · COMPLETED

Trial details

NCT number: NCT00005949
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IV Melanoma

Start date: 2001-03-01
Primary completion: 2006-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.